Orthofix Medical Inc. (NASDAQ: OFIX) stock fell -1.06% on Friday to $13.03 against a previous-day closing price of $13.17. With 1.34 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.34 million shares. The 52-week range on OFIX shows that it touched its highest point at $23.19 and its lowest point at $12.82 during that stretch. It currently has a 1-year price target of $25.75. Beta for the stock currently stands at 0.88.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OFIX was down-trending over the past week, with a drop of -29.07%, but this was down by -28.88% over a month. Three-month performance dropped to -30.69% while six-month performance fell -27.13%. The stock lost -38.91% in the past year, while it has lost -36.53% so far this year. A look at the trailing 12-month EPS for OFIX yields -3.66 with Next year EPS estimates of -0.06. For the next quarter, that number is -0.21. This implies an EPS growth rate of 49.50% for this year and 88.90% for next year. EPS is expected to grow by 9.40% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -25.90%.
Float and Shares Shorts:
At present, 36.76 million OFIX shares are outstanding with a float of 35.87 million shares on hand for trading. On Aug 30, 2023, short shares totaled 0.65 million, which was 1.76% higher than short shares on Jul 30, 2023. In addition to Ms. Kimberley A. Elting as the firm’s Pres of Global Orthopedics, Mr. Kevin J. Kenny serves as its Pres of Global Spine Bus.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, OFIX reported revenue of $118.07M and operating income of -$4.07M. The EBITDA in the recently reported quarter was $16.00k and diluted EPS was $0.12.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OFIX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With OFIX analysts setting a high price target of $35.50 and a low target of $16.00, the average target price over the next 12 months is $25.75. Based on these targets, OFIX could surge 172.45% to reach the target high and rise by 22.79% to reach the target low. Reaching the average price target will result in a growth of 97.62% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded OFIX stock several times over the past three months with 2 Buys and 0 Sells. In these transactions, 13,752 shares were bought while 0 shares were sold. The number of buy transactions has increased to 38 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 933,862 while 72,573 shares were sold.